Spanish study tracks COPD patients on new triple inhaler
NCT ID NCT06321731
Summary
This study looked back at the medical records of 718 adults in Spain with chronic obstructive pulmonary disease (COPD) who started using a triple-combination inhaler called Trixeo Aerosphere. The goal was to see how often patients experienced breathing flare-ups (exacerbations) and how they fared over 12 months of using this medication in everyday life, outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Barcelona, Spain
-
Research Site
Granada, Spain
-
Research Site
Lleida, Spain
-
Research Site
Lugo, Spain
-
Research Site
Madrid, Spain
-
Research Site
Málaga, Spain
-
Research Site
Murcia, Spain
-
Research Site
Ourense, Spain
-
Research Site
Oviedo, Spain
-
Research Site
Palma de Mallorca, Spain
-
Research Site
Santa Cruz de Tenerife, Spain
-
Research Site
Seville, Spain
-
Research Site
Valencia, Spain
-
Research Site
Vitoria-Gasteiz, Spain
-
Research Site
Zaragoza, Spain
Conditions
Explore the condition pages connected to this study.